SULFAMETHOPRIM Drug Patent Profile
✉ Email this page to a colleague
When do Sulfamethoprim patents expire, and what generic alternatives are available?
Sulfamethoprim is a drug marketed by Novel Labs Inc and is included in two NDAs.
The generic ingredient in SULFAMETHOPRIM is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfamethoprim
A generic version of SULFAMETHOPRIM was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULFAMETHOPRIM?
- What are the global sales for SULFAMETHOPRIM?
- What is Average Wholesale Price for SULFAMETHOPRIM?
Summary for SULFAMETHOPRIM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 171 |
| Clinical Trials: | 2 |
| DailyMed Link: | SULFAMETHOPRIM at DailyMed |
Recent Clinical Trials for SULFAMETHOPRIM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Roswell Park Cancer Institute | Phase 4 |
| National Cancer Institute (NCI) | Phase 4 |
| M.D. Anderson Cancer Center | Phase 2 |
US Patents and Regulatory Information for SULFAMETHOPRIM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novel Labs Inc | SULFAMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 070022-001 | Feb 15, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Novel Labs Inc | SULFAMETHOPRIM-DS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 070032-001 | Feb 15, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
